« Return to News | Awards & Advancement

HemoShear appoints Figler scientific director

Monday, February 6, 2012 02:50 PM

HemoShear, a biotechnology research company, has appointed Robert A. Figler, Ph.D., scientific director.

Previously, Figler was director of pharmacology at Adenosine Therapeutics and an assistant professor in the department of molecular physiology and biological physics at the University of Virginia (UVA). He is also a well-published scientist who is a named inventor on seven patents for adenosine analogs, several of which are in human clinical trials. Figler has extensive experience with animal models and in-vitro assays used in drug development.

Figler's primary responsibility will be to lead HemoShear's NIH-funded research efforts to develop an extensive database of drug-induced vascular genomic response profiles using the company's proprietary human-surrogate vascular system.

"HemoShear's business is growing and our needs for additional scientific and operational expertise are increasing," said Jim Powers, HemoShear's CEO. 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.